D3-ZEN 60K

Quick links

Choose a section

Quick links to important sections

Advertisements

D3-ZEN 60K

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of D3-ZEN 60K

What is D3-ZEN 60K?

D3-ZEN 60K is a high-potency supplement containing Cholecalciferol, more commonly known as Vitamin D3. Cholecalciferol is a fat-soluble vitamin that the body naturally synthesizes when the skin is exposed to ultraviolet light from the sun. It is also found in a limited number of food sources, such as oily fish, egg yolks, and fortified products.

This specific formulation provides 60,000 International Units (IU) of Vitamin D3. It is designed to address physiological requirements in individuals who are unable to maintain adequate vitamin levels through sunlight and diet alone.

Role of Vitamin D3 in the Body

Vitamin D3 acts as a hormone precursor and is essential for several fundamental biological processes:

  • Calcium Absorption: It facilitates the absorption of calcium and phosphorus from the gastrointestinal tract, which is necessary for the mineralization of bone tissue.
  • Bone Health: By maintaining appropriate calcium levels, it supports the structural integrity of the skeletal system and helps maintain bone density.
  • Neuromuscular Function: It plays a role in supporting normal muscle function and the transmission of signals between the nervous system and muscles.
  • Immune System Support: It is involved in modulating the body's immune responses.

Therapeutic Purpose

D3-ZEN 60K is primarily utilized to manage Vitamin D deficiency and insufficiency. Clinical deficiency can lead to the softening and weakening of bones, a condition known as rickets in children and osteomalacia in adults. In older populations, maintaining adequate Vitamin D levels is a core component in the management of osteoporosis to reduce the risk of bone fragility.

Regulatory References

  1. MedlinePlus: Vitamin D
Advertisements

What side effects are possible with D3-ZEN 60K?

Possible side effects and safety information

The official safety profile of high-strength Cholecalciferol (Vitamin D3) is primarily structured around the potential for elevated mineral levels in the body, as documented by government regulatory agencies.

Adverse Reaction Scope

Category Regulatory Classification
Primary Critical Events Hypercalcaemia (high blood calcium) and Hypercalciuria (high urine calcium) are listed as Uncommon side effects (affecting 1 in 100 to 1 in 1,000 individuals).
System-Organ Classes Adverse reactions are officially grouped by Metabolism and Nutrition Disorders (primary focus), Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, and Renal and Urinary Disorders.
Other Reactions General gastrointestinal effects (e.g., nausea, vomiting, constipation, abdominal pain) and hypersensitivity reactions (e.g., rash, pruritus) have also been documented, often categorized as frequency Not Known.

Serious Adverse Reactions and Safety Constraints

The most serious outcomes documented in regulatory sources are related to chronic, excessive exposure, which can lead to Vitamin D Intoxication and the potential development of Nephrocalcinosis or Renal Calculi (kidney stones).

Safety Restrictions: The medicine is explicitly restricted for use in individuals with existing conditions such as Hypercalcaemia, Hypercalciuria, or known Vitamin D Intoxication. Safety statements also note particular caution for patients with impaired renal function due to an increased risk of renal complications. The risk of adverse events is generally noted to be associated with prolonged exposure to high doses.

Context-of-Use Notes: Concurrent use with thiazide diuretics or cardiac glycosides requires consideration, as regulatory information indicates these may influence the risk of hypercalcaemia or its systemic consequences.

Advertisements

Overdose and Emergency Response

Overdose with high-strength Cholecalciferol (D3-ZEN 60K) is primarily defined in regulatory documents as Hypervitaminosis D, leading to Hypercalcemia (high calcium levels in the blood).

Documented Manifestations and Severe Outcomes

Official labeling states that overdose may initially present with non-specific symptoms such as nausea, vomiting, loss of appetite, fatigue, headache, constipation, and excessive urination (polyuria) and thirst (polydipsia).

Severe toxicity has the potential for life-threatening organ damage. Documented serious outcomes include acute or irreversible renal failure due to calcium deposits (nephrocalcinosis), the presence of cardiac arrhythmias, and generalized soft tissue calcification. In extreme cases, central nervous system effects such as stupor or coma are officially recognized.

Required Emergency Actions

If overdose is suspected, the regulatory mandate is the immediate discontinuation of the product and any concurrent calcium or vitamin D supplementation. Given the potential for severe outcomes, regulatory guidance requires that patients seek immediate medical attention or contact emergency services for symptoms of collapse, seizure, or signs of acute hypercalcemia.

Supportive Care and Monitoring

There is no specific antidote known. Management is symptomatic and supportive, relying on specialized medical procedures such as aggressive intravenous fluid administration and pharmacological agents to lower serum calcium levels. Hospital monitoring of serum calcium, renal function, and cardiac activity is required until levels stabilize.

Advertisements

Therapeutic Uses of D3-ZEN 60K

What D3-ZEN 60K Treats: Main Uses and Benefits

D3-ZEN 60K is a high-strength therapeutic preparation commonly used to help manage specific medical conditions and associated symptom patterns resulting from severe, clinically confirmed Vitamin D deficiency. The primary focus is on supporting the body’s essential mineral balance and contributing to foundational support for structural health. The supplement is relevant for the therapeutic management of conditions such as rickets, osteomalacia, and as supportive therapy for osteoporosis.

This medication is considered relevant for the therapeutic management of chronic or severe deficiency states. It is commonly applied in metabolic bone disorders where there is impaired bone mineralization associated with the deficit. Addressing the vitamin status generally assists with supporting muscle function and strength. The preparation is relevant for providing supportive care to patient groups with a heightened risk of deficiency, including older adults, individuals with malabsorption syndromes, and patients with chronic kidney disease.

“The preparation may help ease the overall symptom burden and contribute to improved physical stability during periods of heightened discomfort.”

Quick Fact: Relief for Musculoskeletal Discomfort D3-ZEN 60K is commonly used when symptoms cluster into patterns of bone aching and weakness, assisting with supporting structural integrity and helping improve day-to-day comfort.

Regulatory References

  1. NIH MedlinePlus overview of Cholecalciferol (Vitamin D3)
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use D3-ZEN 60K?

D3-ZEN 60K is officially established for use in Adults for the treatment of documented Vitamin D deficiency and as an adjunct to specific osteoporosis therapy.

Contraindications and Prohibited Use

Use of the medicine is strictly contraindicated in patients with a history of Hypersensitivity to its components, or those exhibiting Hypervitaminosis D (toxicity), Hypercalcemia (high blood calcium), or Hypercalciuria (high urinary calcium). Use is also prohibited in cases of Severe Renal Impairment and when Nephrolithiasis (kidney stones) is present.

Age and Life Stage Restrictions

The high-strength formulation is not recommended for use in Children and Adolescents (under 18 years of age) due to insufficient data for high doses in this population. Similarly, the 60,000 IU strength is not recommended during pregnancy or lactation; where deficiency exists, a low-strength product should be used.

Conditional Use and Caution

Use must be accompanied by Caution and specific monitoring in certain populations. This includes patients with non-severe Impairment of renal function and those with conditions like Sarcoidosis. Regulatory labels state that a dose adjustment is generally not required for patients with Hepatic Impairment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of D3-ZEN 60K (Cholecalciferol) through substances that affect its availability or compound its effects on mineral balance. No drug-drug combination is formally listed as an absolute contraindication based solely on the interaction risk.

Interaction Type Interacting Agents / Classes
Reduced Exposure (Absorption) Bile Acid Sequestrants (e.g., Cholestyramine); Lipase Inhibitors (e.g., Orlistat).
Reduced Exposure (Catabolism) Anticonvulsants (e.g., Phenytoin, Phenobarbital).
Additive Effects (Hypercalcemia) Thiazide Diuretics; High-dose Calcium Salts; Cardiac Glycosides (e.g., Digoxin).

Certain medicinal products and supplements are documented to diminish D3-ZEN 60K's absorption. Agents such as bile acid sequestrants and lipase inhibitors may interfere with the uptake of the fat-soluble Cholecalciferol. Separately, specific enzyme-inducing anticonvulsants are known to accelerate the metabolic breakdown of Cholecalciferol, resulting in lower levels.

Pharmacodynamic Risk and Timing Constraints:

The most significant interaction risk is the potential for an additive hypercalcemic effect when co-administered with thiazide diuretics or calcium supplements. High calcium levels can heighten the risk of toxicity from Cardiac Glycosides. Additionally, regulatory information notes that administration must be separated from Aluminum-containing Antacids to prevent interference with absorption, and caution is warranted for this co-administration, particularly in populations with Renal Impairment.

Advertisements

Mechanism of Action

How D3-ZEN 60K Works

D3-ZEN 60K is a cholecalciferol formulation. Following systemic absorption, it undergoes initial hepatic 25-hydroxylation to calcifediol, which is subsequently converted in the kidney via 1-alpha-hydroxylase into the active hormone, calcitriol (1,25( OH)2 D3). Calcitriol acts as a ligand for the Vitamin D Receptor (VDR), a nuclear receptor.

The ligand-receptor complex then heterodimerizes with the Retinoid X Receptor (RXR) and translocates into the nucleus. Within the nucleus, the VDR-RXR complex binds to specific Vitamin D Response Elements (VDREs) on target gene promoters, initiating changes in gene transcription. This transcriptional modification modulates the intestinal absorption of calcium and phosphate ions and directly influences the activity of bone cells. Specifically, it modulates osteoclast activity to alter the net bone resorption rate, and influences the differentiation and mineralization capacity of osteoblasts, affecting systemic calcium regulation and bone turnover markers.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

D3-ZEN 60K (Cholecalciferol 60,000 IU) is a high-strength preparation intended for the initial corrective phase of severe micronutrient deficiency. Its usage is governed by specific guidelines that define the route, timing, and duration of the therapeutic course.


Administration Schedule and Conditions

Instruction General Guidance
Route of Administration Oral (Capsule, tablet, or solution form)
Dosing Regimen 60,000 IU once weekly
Timing in Relation to Meals Must be taken with or immediately after a meal to enhance the absorption of the fat-soluble active ingredient
Course Duration Typically prescribed for a defined, short-term loading course, such as 8 weeks, before switching to maintenance.

Procedural and Population Rules

Official procedural structure: The treatment protocol is structured to deliver the high dose weekly for a limited time to replenish body stores. Upon completing this corrective phase, the patient must transition to a lower daily maintenance dose (e.g., 800 IU to 2,000 IU) as the 60,000 IU strength is not intended for long-term daily use.

Missed-dose rule: If a dose is missed, it should be taken as soon as it is remembered. However, no double dose must be taken to compensate for the forgotten dose, maintaining the regular weekly schedule thereafter.

Population notes: Administration to pediatric patients requires the dosage and use to be prescribed by a physician. Similarly, use in patients with impaired renal or hepatic function may require adjustment under close medical supervision.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research into the Compound's Action

Research focused on the compound's potential relevance for discomfort and immune response. Studies investigated the compound's activity relative to certain biological targets, and research has investigated whether it may be relevant for chronic X.


Clinical Trials and Efficacy

Studies have been conducted to evaluate the compound's potential effects in humans.

Early-Stage Trials

Initial trials primarily assessed the compound's tolerability across different levels of exposure and examined how the compound is processed by the body. Certain trials utilized a protocol that involved low initial exposure. Studies noted that the compound's half-life was relatively short; subsequent research aimed to investigate formulations that might extend its presence in the body. Long-term studies have been conducted to evaluate the compound's profile.

Phase III Studies

Large-scale, randomized controlled trials (RCTs) have been the primary method for investigating the compound's potential effects.

  • Study Group A: This research evaluated whether the compound is associated with changes in quality of life in individuals with X over a 12-week period. The primary endpoint measured patient-reported comfort levels.
  • Study Group B: This study explored the compound's use in combination with standard care. Some studies have investigated the compound's use alongside physical therapy. This combination has been evaluated to explore whether it is associated with a sustained change in symptoms.
  • Study Group C: Research has evaluated whether the compound is associated with changes in pain and inflammation.

Subgroup Analysis and Safety Profile

Research has examined the use of this compound in people with pre-existing conditions, such as liver disease. Findings from these subgroup analyses were mixed regarding changes in markers of liver function.

Head-to-head trials have compared the compound against existing treatments. Research has investigated whether one treatment group reported fewer discomfort-related symptoms than the other in a six-month follow-up study. The primary outcomes across multiple studies included reports of mild and temporary effects, such as mild gastrointestinal upset and fatigue.


Ongoing Research

Ongoing studies are seeking to further clarify the compound's long-term effects and its potential application in other related conditions. It is not yet clear whether the observed changes are directly attributable to the compound or to other factors.

Key Studies & References

  1. Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS) - NCT04094688
  2. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: U.S. Preventive Services Task Force Recommendation Statement
  3. Cholecalciferol (Vitamin D3) FDA Drug Monograph/Labeling (Used to model general vitamin D safety profile)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about D3-ZEN 60K (FAQ)


Q: Can I take D3-ZEN 60K in the morning or at night?

Official information confirms that Cholecalciferol is a fat-soluble vitamin. Administration conditions indicate that taking it with or immediately after a meal is necessary to promote its absorption. Regulatory documents do not specify a preferred time of day, such as morning versus night, as the key factor is the presence of food and bile.

Q: Does this medicine contain any common allergens like gluten or soy?

Product labels for Cholecalciferol supplements list the active ingredient alongside inactive ingredients. Specific formulations, particularly softgel capsules, may contain components such as Soybean oil or Soy Lecithin. Due to variations between specific products, regulatory guidelines advise referring to the official product label for detailed allergen information.

Q: How long will it take for D3-ZEN 60K to start working and for me to feel a difference?

Regulatory documents note that there is a time lag of approximately 10 to 24 hours between administering Vitamin D (cholecalciferol) and the initiation of its action in the body. This delay is due to the body's need to convert cholecalciferol into its active forms within the liver and kidneys.

Q: Does D3-ZEN 60K interact with common pain relievers like acetaminophen?

Drug interaction resources for cholecalciferol generally do not list an interaction with common pain relievers such as acetaminophen (paracetamol). Official guidelines emphasize the importance of communicating all current medications, vitamins, and supplements to a healthcare professional.

Q: Will taking D3-ZEN 60K make me feel sleepy or affect my mood?

Official safety information primarily lists adverse effects associated with hypervitaminosis D (excessive vitamin D intake). These effects can include central nervous system changes, such as mental/mood changes, confusion, or unusual tiredness.

Q: Do I need a blood test to check my Vitamin D levels before starting D3-ZEN 60K?

When high therapeutic doses of Vitamin D are used, regulatory information recommends that progress should be followed with frequent blood calcium determinations. This monitoring is a standard procedure to prevent the risk of hypervitaminosis D.

Q: Will D3-ZEN 60K raise my blood pressure or cause hair loss?

Regulatory safety data indicates that excessive levels of Vitamin D (hypervitaminosis D) can potentially lead to symptoms including hypertension (high blood pressure). However, hair loss is not typically listed as a documented adverse reaction in the authoritative drug information.

Q: What is the maximum dose of cholecalciferol I can take safely?

Regulatory documents emphasize that use must be limited to the dosage prescribed by a physician. Official statements indicate that use in excess of the Recommended Dietary Allowance (RDA) during pregnancy should be avoided to prevent the risk of toxicity.

Q: Does D3-ZEN 60K show up on a drug screening test?

Cholecalciferol (Vitamin D3) is generally classified as a vitamin and is not typically included in the list of substances screened for during common drug tests.

Q: Is the soft gelatin coating required for absorption?

Regulatory information indicates that Cholecalciferol is fat soluble, meaning oral formulations rely on the presence of bile for adequate intestinal absorption. While the specific softgel or capsule design facilitates consumption, the requirement for dietary fat remains the key factor for absorption.

Advertisements

How should D3-ZEN 60K be stored and disposed of?

How to Store and Dispose of D3-ZEN 60K

Official regulatory documents define strict environmental controls necessary for storing D3-ZEN 60K (Cholecalciferol) to maintain stability.

Storage and Handling Mandates

The product must be stored at a Controlled Room Temperature, not exceeding 25 C. It is mandatory to keep the medicine in its original package and within a tight, light-resistant container to shield the active ingredient from light and moisture. The preparation must be protected from direct sunlight and should not be frozen.

Disposal and Safety Requirements

All labeling includes the instruction to keep D3-ZEN 60K out of the sight and reach of children to prevent accidental ingestion.

Disposal of unused or expired medicine must follow local governmental regulations. Regulatory bodies advise against disposing of the product in household waste or flushing it down a toilet or sink, instead recommending the use of authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of D3-ZEN 60K found in:

A-Z Index: